This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Business / Mineralys Therapeutics to attend...
Business conference participation

Mineralys Therapeutics to attend Goldman Sachs conference

Analysis based on 7 articles · First reported Jun 08, 2026 · Last updated Jun 08, 2026

Sentiment
10
Attention
2
Articles
7
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The participation of MiNK Therapeutics in the Goldman Sachs conference could lead to increased investor awareness and potential interest in its stock. This event provides a platform for MiNK Therapeutics to showcase its product candidate, lorundrostat, to a broader financial market audience.

Biotechnology Pharmaceuticals
Event Summary

MiNK Therapeutics announced its participation in the Goldman Sachs 47th Annual Global Healthcare Conference, held in Miami from June 8-10, 2026. Management from MiNK Therapeutics will engage in a fireside chat on June 9, 2026, at 2:40 PM ET, which will be webcast live. This event offers MiNK Therapeutics an opportunity to discuss its focus on developing medicines for hypertension and related comorbidities, including its product candidate, lorundrostat, a selective aldosterone synthase inhibitor. MiNK Therapeutics was founded by Catalys Pacific.

Entities Involved
stock
MiNK Therapeutics
MiNK Therapeutics is participating in a major healthcare conference, which provides an opportunity to present its product candidate, lorundrostat, and potentially attract investor interest, positively impacting its visibility and stock.
Importance 100.0 Sentiment 10.0
stock
Goldman Sachs
Goldman Sachs is hosting the 47th Annual Global Healthcare Conference, providing a platform for companies like MiNK Therapeutics to engage with investors and industry professionals.
Importance 50.0 Sentiment 0.0
priv
Catalys Pacific
Catalys Pacific founded MiNK Therapeutics, indicating its initial involvement in the company's establishment.
Importance 10.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.